Titre : Hypersensibilité au blé

Hypersensibilité au blé : Questions médicales fréquentes

Termes MeSH sélectionnés :

Observer Variation
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hypersensibilité au blé : Questions médicales les plus fréquentes", "headline": "Hypersensibilité au blé : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hypersensibilité au blé : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-19", "dateModified": "2025-02-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hypersensibilité au blé" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hypersensibilité alimentaire", "url": "https://questionsmedicales.fr/mesh/D005512", "about": { "@type": "MedicalCondition", "name": "Hypersensibilité alimentaire", "code": { "@type": "MedicalCode", "code": "D005512", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.543.480.370" } } }, "about": { "@type": "MedicalCondition", "name": "Hypersensibilité au blé", "alternateName": "Wheat Hypersensitivity", "code": { "@type": "MedicalCode", "code": "D021182", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Francesca Mori", "url": "https://questionsmedicales.fr/author/Francesca%20Mori", "affiliation": { "@type": "Organization", "name": "Allergy Unit, Department of Pediatrics, Meyer Children's University Hospital, Florence, Italy." } }, { "@type": "Person", "name": "J Lane Wilson", "url": "https://questionsmedicales.fr/author/J%20Lane%20Wilson", "affiliation": { "@type": "Organization", "name": "Department of Community and Family Medicine, University of Missouri Kansas City School of Medicine, University Health Lakewood Medical Center, 7900 Lee's Summit Road, Kansas City, MO 64139, USA. Electronic address: lane.wilson@uhkc.org." } }, { "@type": "Person", "name": "Bridgid Wilson", "url": "https://questionsmedicales.fr/author/Bridgid%20Wilson", "affiliation": { "@type": "Organization", "name": "Department of Community and Family Medicine, University Health Lakewood Medical Center, Kansas City, MO, USA." } }, { "@type": "Person", "name": "Stefan Kefer", "url": "https://questionsmedicales.fr/author/Stefan%20Kefer", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Jixiang Dai", "url": "https://questionsmedicales.fr/author/Jixiang%20Dai", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study.", "datePublished": "2023-04-11", "url": "https://questionsmedicales.fr/article/37100018", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jns.2023.120646" } }, { "@type": "ScholarlyArticle", "name": "Interobserver variation in clinical target volume (CTV) delineation for stereotactic radiotherapy to non-spinal bone metastases in prostate cancer: CT, MRI and PET/CT fusion.", "datePublished": "2023-01-09", "url": "https://questionsmedicales.fr/article/36634852", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.radonc.2022.109461" } }, { "@type": "ScholarlyArticle", "name": "Inter- and intra-observer variability in the echocardiographic evaluation of wall motion abnormality in patients with ST-elevation myocardial infarction or takotsubo syndrome - A novel approach.", "datePublished": "2023-06-26", "url": "https://questionsmedicales.fr/article/37363868", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/echo.15638" } }, { "@type": "ScholarlyArticle", "name": "Inter-observer variability between readers in detection of bone metastases comparing different modalities; PET/CT, SPECT/CT and planar bone scintigraphy.", "datePublished": "2023-04-28", "url": "https://questionsmedicales.fr/article/37114413", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MNM.0000000000001704" } }, { "@type": "ScholarlyArticle", "name": "Impact of observer experience on multi-detector computed tomography aortic valve morphology assessment and valve size selection for transcatheter aortic valve replacement.", "datePublished": "2022-12-12", "url": "https://questionsmedicales.fr/article/36509862", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-022-23936-w" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007154" }, { "@type": "ListItem", "position": 3, "name": "Hypersensibilité", "item": "https://questionsmedicales.fr/mesh/D006967" }, { "@type": "ListItem", "position": 4, "name": "Hypersensibilité immédiate", "item": "https://questionsmedicales.fr/mesh/D006969" }, { "@type": "ListItem", "position": 5, "name": "Hypersensibilité alimentaire", "item": "https://questionsmedicales.fr/mesh/D005512" }, { "@type": "ListItem", "position": 6, "name": "Hypersensibilité au blé", "item": "https://questionsmedicales.fr/mesh/D021182" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hypersensibilité au blé - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hypersensibilité au blé", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hypersensibilité au blé", "description": "Comment diagnostiquer l'hypersensibilité au blé ?\nQuels tests sont utilisés pour le diagnostic ?\nLes tests d'allergie sont-ils fiables ?\nPeut-on confondre avec d'autres allergies ?\nQuel rôle joue l'historique médical ?", "url": "https://questionsmedicales.fr/mesh/D021182?mesh_terms=Observer+Variation&page=7#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hypersensibilité au blé", "description": "Quels sont les symptômes courants ?\nLes symptômes apparaissent-ils immédiatement ?\nY a-t-il des symptômes respiratoires ?\nLes symptômes varient-ils d'une personne à l'autre ?\nPeut-on avoir des symptômes chroniques ?", "url": "https://questionsmedicales.fr/mesh/D021182?mesh_terms=Observer+Variation&page=7#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hypersensibilité au blé", "description": "Comment prévenir l'hypersensibilité au blé ?\nLes enfants peuvent-ils développer cette hypersensibilité ?\nY a-t-il des aliments à éviter ?\nLes substituts au blé sont-ils sûrs ?\nComment informer les autres de l'allergie ?", "url": "https://questionsmedicales.fr/mesh/D021182?mesh_terms=Observer+Variation&page=7#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hypersensibilité au blé", "description": "Quel est le traitement principal ?\nDes médicaments sont-ils nécessaires ?\nQue faire en cas d'anaphylaxie ?\nY a-t-il des traitements alternatifs ?\nLe traitement est-il à vie ?", "url": "https://questionsmedicales.fr/mesh/D021182?mesh_terms=Observer+Variation&page=7#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hypersensibilité au blé", "description": "Quelles complications peuvent survenir ?\nL'hypersensibilité peut-elle entraîner d'autres allergies ?\nY a-t-il un risque de malnutrition ?\nComment gérer les complications ?\nLes complications sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D021182?mesh_terms=Observer+Variation&page=7#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hypersensibilité au blé", "description": "Quels sont les facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes allergies saisonnières augmentent-elles le risque ?\nLe mode de vie joue-t-il un rôle ?\nLes infections peuvent-elles influencer le risque ?", "url": "https://questionsmedicales.fr/mesh/D021182?mesh_terms=Observer+Variation&page=7#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'hypersensibilité au blé ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'anamnèse, les tests cutanés et les analyses sanguines spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests IgE spécifiques et les tests de provocation orale sont couramment utilisés." } }, { "@type": "Question", "name": "Les tests d'allergie sont-ils fiables ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont généralement fiables, mais doivent être interprétés par un allergologue." } }, { "@type": "Question", "name": "Peut-on confondre avec d'autres allergies ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être similaires à d'autres allergies alimentaires, nécessitant des tests." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier les déclencheurs et à orienter le diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes courants ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent démangeaisons, éruptions cutanées, troubles digestifs et anaphylaxie." } }, { "@type": "Question", "name": "Les symptômes apparaissent-ils immédiatement ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent apparaître rapidement, dans les minutes suivant l'ingestion, ou plus tard." } }, { "@type": "Question", "name": "Y a-t-il des symptômes respiratoires ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme l'asthme ou la rhinite peuvent survenir chez certains patients." } }, { "@type": "Question", "name": "Les symptômes varient-ils d'une personne à l'autre ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et le type de symptômes peuvent varier considérablement entre les individus." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes chroniques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent éprouver des symptômes chroniques liés à l'exposition au blé." } }, { "@type": "Question", "name": "Comment prévenir l'hypersensibilité au blé ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les aliments contenant du blé et lire attentivement les étiquettes des produits." } }, { "@type": "Question", "name": "Les enfants peuvent-ils développer cette hypersensibilité ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent développer une hypersensibilité au blé, surtout s'ils ont des antécédents familiaux." } }, { "@type": "Question", "name": "Y a-t-il des aliments à éviter ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Tous les produits contenant du blé, y compris le pain, les pâtes et les céréales, doivent être évités." } }, { "@type": "Question", "name": "Les substituts au blé sont-ils sûrs ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Certains substituts comme le riz ou le maïs sont sûrs, mais vérifiez toujours les étiquettes." } }, { "@type": "Question", "name": "Comment informer les autres de l'allergie ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Informez les amis, la famille et les restaurants de votre hypersensibilité pour éviter les risques." } }, { "@type": "Question", "name": "Quel est le traitement principal ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "L'évitement strict du blé est le traitement principal pour prévenir les réactions." } }, { "@type": "Question", "name": "Des médicaments sont-ils nécessaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des antihistaminiques peuvent être prescrits pour soulager les symptômes légers." } }, { "@type": "Question", "name": "Que faire en cas d'anaphylaxie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser un auto-injecteur d'épinéphrine et appeler les urgences immédiatement." } }, { "@type": "Question", "name": "Y a-t-il des traitements alternatifs ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certaines thérapies complémentaires peuvent aider, mais leur efficacité n'est pas prouvée." } }, { "@type": "Question", "name": "Le traitement est-il à vie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'évitement du blé est généralement nécessaire à vie pour éviter les symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme l'anaphylaxie, des troubles digestifs chroniques ou des carences nutritionnelles peuvent survenir." } }, { "@type": "Question", "name": "L'hypersensibilité peut-elle entraîner d'autres allergies ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes allergiques au blé peuvent développer d'autres allergies alimentaires." } }, { "@type": "Question", "name": "Y a-t-il un risque de malnutrition ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'évitement du blé peut entraîner des carences si l'alimentation n'est pas bien équilibrée." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une consultation régulière avec un allergologue et un diététicien est recommandée." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications ne sont pas fréquentes si l'hypersensibilité est bien gérée et évitée." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux d'allergies et l'exposition précoce au blé augmentent le risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants sont plus susceptibles de développer une hypersensibilité au blé." } }, { "@type": "Question", "name": "Les allergies saisonnières augmentent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes ayant des allergies saisonnières peuvent avoir un risque accru d'allergies alimentaires." } }, { "@type": "Question", "name": "Le mode de vie joue-t-il un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain et une alimentation équilibrée peuvent réduire le risque d'allergies." } }, { "@type": "Question", "name": "Les infections peuvent-elles influencer le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections précoces peuvent influencer le développement d'allergies alimentaires." } } ] } ] }

Sources (10000 au total)

Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study.

Uniform case definitions are required to ensure harmonised reporting of neurological syndromes associated with SARS-CoV-2. Moreover, it is unclear how clinicians perceive the relative importance of SA... We invited clinicians through global networks, including the World Federation of Neurology, to assess ten anonymised vignettes of SARS-CoV-2 neurological syndromes. Using standardised case definitions... 1265 diagnoses were assigned by 146 participants from 45 countries on six continents. The highest correct proportion were cerebral venous sinus thrombosis (CVST, 95.8%), Guillain-Barré syndrome (GBS, ... The case definitions can help with reporting of neurological complications of SARS-CoV-2, also in settings with few neurologists. However, encephalopathy, encephalitis, and psychosis were often misdia...

Interobserver variation in clinical target volume (CTV) delineation for stereotactic radiotherapy to non-spinal bone metastases in prostate cancer: CT, MRI and PET/CT fusion.

The use of SBRT for the treatment of oligometastatic prostate cancer is increasing rapidly. While consensus guidelines are available for non-spinal bone metastases practice continues to vary widely. T... 15 metastases from 13 patients treated at our centre were selected. 4 observers independently contoured clinical target volumes (CTV) on planning CT alone, planning CT with MRI fusion, planning CT wit... Mean CTV volume delineated on planning CT with MRI and PET-CT fusion combined was significantly larger compared to other imaging modalities (p = 0.0001). CIgen showed marked variation between modaliti... Highest consistency in CTV delineation between observers was seen with planning CT + PET-CT and planning CT + PET-CT + MRI combined....

Inter- and intra-observer variability in the echocardiographic evaluation of wall motion abnormality in patients with ST-elevation myocardial infarction or takotsubo syndrome - A novel approach.

Using existing transthoracic echocardiographic indices to quantify left ventricular wall motion abnormalities (WMAs) can be difficult due to the variations in the location of the abnormalities within ... The study included 140 echocardiograms from 54 patients presenting with ST-elevation myocardial infarction or Takotsubo syndrome. All patients underwent an echocardiographic examination according to a... Inter- and intra-observer variability for PrA and PrAH were low and comparable to those for WMSI.... PrA and PrAH are reliable and reproducible echocardiographic methods for the evaluation of left ventricular wall motion....

Inter-observer variability between readers in detection of bone metastases comparing different modalities; PET/CT, SPECT/CT and planar bone scintigraphy.

To assess the inter-observer variability between readers in the detection of bone metastases for different modalities [planar bone scintigraphy (BS), single photon emission computed tomography/compute... Patients with known primary tumors referred for metastatic workup either by F-18 FDG PET/CT or conventional planar BS and SPECT/CT were enrolled in this prospective study. The three modalities (BS, SP... A total of 54 patients (39 females and 15 males, ages 26-76; mean: 54.7 ± 12) were eligible for this study. Fair agreement 0.372 between R1 and R2 in interpretation of BS was noticed that improved to ... F-18 FDG PET/CT significantly improved the inter-observer variability between readers, allowing for better diagnosis of bone metastases in known cancer patients. Also, it was superior to BS and SPECT/...

Impact of observer experience on multi-detector computed tomography aortic valve morphology assessment and valve size selection for transcatheter aortic valve replacement.

Transcatheter aortic valve replacement (TAVR) has become the standard treatment for aortic stenosis in older patients. It increasingly relies on accurate pre-procedural planning using multidetector co...

Inter-observer agreement of tumor infiltrating lymphocytes in primary HER2-positive breast cancer and correlation between tissue microarray and full tumor-sections.

Tumor infiltrating lymphocytes (TILs) have predictive and prognostic potential in HER2-positive breast cancer (HER2 + BC). Due to tumor heterogeneity, guidelines recommend evaluation on full tumor-sec...

Assessment of inter-rater and intra-rater reliability of the Luna EMG robot as a tool for assessing upper limb proprioception in patients with stroke-a prospective observational study.

The aim of the study was to assess the inter-rater and intra-rater agreement of measurements performed with the Luna EMG (electromyography) multifunctional robot, a tool for evaluation of upper limb p... The study was conducted in a group of patients with chronic stroke. A total of 126 patients participated in the study, including 78 women and 48 men, on average aged nearly 60 years (mean = 59.9). Pro... High consistency of the measurements performed for the right and the left hand was reflected by the interclass correlation coefficients (0.996-0.998 and 0.994-0.999, respectively) and by Pearson's lin... Measurements performed by the Luna EMG diagnostic and rehabilitation robot demonstrate high inter-rater and intra-rater agreement in the assessment of upper limb proprioception in patients with chroni...

Overcoming inter-observer planning variability in target volume contouring and dose planning for high-risk neuroblastoma - a European multicenter effort of the SIOPEN radiotherapy committee.

To establish an international quality standard for contouring and planning for high-risk neuroblastoma within the prospective High-Risk Neuroblastoma Study 2 of SIOP-Europe-Neuroblastoma (SIOPEN HR-NB... Data on four patients with high-risk neuroblastoma were selected and distributed to the radiotherapy committee of the HR-NBL2 study for independent contouring and planning. Differences in contouring w... Substantial agreement was found for contouring of the heart (0.64), liver (0.70), left lung (0.74), and right lung (0.74). For contouring of the gastrointestinal tract (0.54), left kidney (0.60), and ... Considerable variability was found for the delineation of target volumes, particularly the boost volume, whereas the contouring of the organs at risk and the planning strategy were reasonably consiste...

Intra and interobserver agreement of the Dynamic Imaging Grade of Swallowing Toxicity Scale (DIGEST) in fiberoptic endoscopic evaluation of swallowing (FEES): the importance of observer-tailored training.

The Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) is a scale to quantify the severity of pharyngeal dysphagia in head and neck cancer (HNC) patients. This study (1) described the training proc... Twenty-seven dysphagic HNC patients were enrolled. Two observers completed a training program for DIGEST in FEES. Observer agreement on the Penetration-Aspiration Scale (PAS), percentage of pharyngeal... Due to insufficient observer agreement after the first measurement attempt, additional training was organized using an elaborated manual with descriptions of the visuoperceptual variables, thereby imp... The DIGEST showed to be a reproducible measurement for FEES in terms of observer agreement. However, agreement between novice observers on the DIGEST was only reached after specific observer-tailored ...

Artificial intelligence-powered programmed death ligand 1 analyser reduces interobserver variation in tumour proportion score for non-small cell lung cancer with better prediction of immunotherapy response.

Manual evaluation of programmed death ligand 1 (PD-L1) tumour proportion score (TPS) by pathologists is associated with interobserver bias.... This study explored the role of artificial intelligence (AI)-powered TPS analyser in minimisation of interobserver variation and enhancement of therapeutic response prediction.... A prototype model of an AI-powered TPS analyser was developed with a total of 802 non-small cell lung cancer (NSCLC) whole-slide images. Three independent board-certified pathologists labelled PD-L1 T... Without AI assistance, pathologists concordantly classified TPS in 81.4% of the cases. They revised their initial interpretation by using the AI model for the disagreement cases between the pathologis... The AI-powered TPS analyser assistance improves the pathologists' consensus of reading and prediction of the therapeutic response, raising a possibility of standardised approach for the accurate inter...